Beta Bionics BBNX
NASDAQ BBNX
$18.92 -1.09 (-5.45%)
At close: Aug 20, 2026 · 1:10 PM UTC

Beta Bionics (BBNX) Return on Assets (2025 - 2026)

Beta Bionics (BBNX) posted Return on Assets of 0.01% for Q2 2026, down 8.02% sequentially from 0.01% in Q1 2026, and little changed YoY from 0.01% in Q2 2025.

Beta Bionics (BBNX) Return on Assets (2025 - 2026) Analysis & Trends

Beta Bionics has reported Return on Assets for 2 years, with the latest figure at 0.01% in Q2 2026.

  • Quarterly Return on Assets changed 0.0% year-over-year to 0.01% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
  • Return on Assets slipped to 0.01% in Q2 2026 per BBNX's latest filing, from 0.01% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q1 2025 and troughed at 0.01% in Q2 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Abbott Laboratories 199.24 Bn 193.64 Bn 7.27 Bn 0.00%
2 Stryker 128.63 Bn 125.15 Bn 4.50 Bn 0.00%
3 Medtronic 119.19 Bn 109.97 Bn 6.41 Bn 0.00%
4 Boston Scientific 73.51 Bn 72.97 Bn 3.85 Bn 0.00%
5 Edwards Lifesciences 52.11 Bn 47.85 Bn 1.35 Bn 0.00%
6 Dexcom 34.64 Bn 32.70 Bn 830.00 Mn 0.00%
7 GE HealthCare Technologies 34.01 Bn 31.90 Bn 2.18 Bn 0.00%
8 Koninklijke Philips 26.40 Bn 23.08 Bn 4.55 Bn 0.00%
9 Steris 23.14 Bn 22.65 Bn 684.20 Mn 0.00%
10 Beta Bionics 842.80 Mn 662.31 Mn 18.90 Mn 0.00%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.01%
Mar 31, 2026 -0.01%
Dec 31, 2025 -0.01%
Sep 30, 2025 -0.01%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%